The overall survival and surgical outcome of the patients with PTA has much improved since 1965 when the complete repair of this defect was reported by McGoon et al. (
4). The most important non cardiac abnormality in these patients is micro deletion of chromosome 22q11.2 which is frequently seen in those who have conotruncal defects including patients with PTA (
5). Although, we could not perform cytogenetic studies, our patient was not syndromic and received routine vaccinations including BCG vaccine without any complication. Although the number of reported cases of PTA type B is limited in literature, there has been a high rate of associated cardiac anomalies among these patients such as hypoplastic left ventricle, hypoplastic right ventricle or truncal valve malfunctioning. Very often these patients were considered inoperable (
6-
10).
Our patient, a 7-month old boy with type B1, tolerated the complete surgical repair after release of left ventricle outflow tract obstruction and use of a homograft for right ventricle outflow tract reconstruction while having systemic pulmonary arterial pressure. Juaneda et al. have reported the pattern of pulmonary vascular damage in children with PTA, based on quantitative, morphometric techniques in the lung biopsy and/or postmortem studies (
11). Their study showed that structural pulmonary abnormalities may potentially be reversible even in infants with pulmonary vascular resistance ≥ 8 units/m
2. They concluded that beyond the first year of life the pulmonary vascular disease may progress despite successful surgical repair. While our patient had systemic pulmonary arterial pressure at the time of complete surgical repair, 4 months later the pulmonary pressure was normal, although she was on sildenafil 0.5 mg/kg per dose 3 times a day.
Long-term follow-up of the patients with repaired PTA have demonstrated the need for surgical or catheter based reintervention, especially for right ventricular outflow tract obstruction or truncal valve dysfunction (
12). Therefore, on long-term follow-up our patient needs close monitoring for functional status, pulmonary arterial pressure, inevitable homograft replacement or revision and regular assessment of function of neoaorta.